InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Sepp-Lorenzino Laura, Directeur Scientifique. Insider active across 1 companies, notably Intellia Therapeutics, Inc.. In total, 5 filings have been logged. The latest transaction was disclosed on 30 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations5 total
3,500 shares
Common Stock
SEC:0001209191-22-015976:0·
€306,69127,000 shares@ €11.35890.016% mcap51.0% of flow
Common Stock
SEC:0001209191-21-054321·
€306,69127,000 shares@ €11.35890.016% mcap25.5% of flow
Common Stock
SEC:0001209191-21-054321:0·
€294,32126,000 shares@ €11.32010.015% mcap49.0% of flow
Common Stock
SEC:0001209191-21-050228·
€294,32126,000 shares@ €11.32010.015% mcap24.5% of flow
Common Stock
SEC:0001209191-21-050228:0·
5 of 5 declarations
About Sepp-Lorenzino Laura
Laura Sepp-Lorenzino is the Chief Scientific Officer at Intellia Therapeutics, Inc. She is responsible for leading scientific initiatives and research within the company. Laura Sepp-Lorenzino plays a key role in developing new therapies and scientific innovation. Her expertise in research is crucial for Intellia's mission.
